Akzo Nobel (AKZA) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Achieved fourth consecutive quarter of volume growth, with Q3 2024 organic sales and volumes up 1% year-over-year, but revenue declined 3% due to adverse currency effects and flat price/mix.
Adjusted gross margin expanded by 60 bps in Q3 and 180 bps YTD; adjusted EBITDA was €400 million (15% margin), or €394 million post hyperinflation accounting, in line with guidance.
Operating income fell 27% to €259 million, impacted by €44 million in restructuring-related items and higher operating costs; operating expenses were higher year-over-year but declined sequentially.
Transformation initiatives include closure of three Deco EMEA sites, SG&A reductions targeting 2,000 positions, and a strategic portfolio review in South Asia, aiming for over €250 million in industrial efficiency benefits by 2027.
Net income attributable to shareholders rose to €521 million year-to-date, with EPS from total operations at €3.05.
Financial highlights
Q3 2024 revenue was €2,668 million (down 3% year-over-year); organic sales grew 1%.
Adjusted EBITDA margin was 14.8% in Q3 (down from 15.1% in Q3 2023); year-to-date margin at 14.3% (up from 13.7%).
Free cash flow in Q3 was €83 million, down from €380 million in Q3 2023, due to temporarily higher working capital.
Net income for Q3 was €521 million, up from €401 million in Q3 2023; adjusted EPS from continuing operations was €1.14, up from €0.99.
Net debt at €4,069 million, leverage ratio at 3.0x net debt/EBITDA.
Outlook and guidance
Full-year 2024 adjusted EBITDA expected around €1.5 billion; net debt/EBITDA ratio targeted at 2.7x by year-end, higher than previous guidance due to working capital and restructuring impacts.
Q4 volumes expected to be flat overall, with continued softness in China Decorative and industrial coatings, but mid-single-digit growth in Latin America and Southeast Asia Deco.
Cost inflation expected to normalize in 2025, with OpEx anticipated to be below 2024 levels due to ongoing cost actions.
Pricing discipline to continue, with early 2025 price increases planned to offset inflation and tariffs.
Stable dividend policy maintained; CAPEX at €320 million for 2024.
Latest events from Akzo Nobel
- Flat sales, margin gains, and India divestment set stage for Axalta merger and future growth.AKZA
Q4 20253 Feb 2026 - Q2 2024 saw 2% organic sales growth, stable EBITDA, and strong Performance Coatings results.AKZA
Q2 20243 Feb 2026 - Adjusted EBITDA rose 3% to €1.5 billion, with 2025 guidance set above €1.55 billion.AKZA
Q4 20249 Jan 2026 - Q1 EBITDA held at €357m as cost actions offset lower volumes; 2025 guidance reaffirmed.AKZA
Q1 202521 Dec 2025 - 2024 results, strategic focus, and governance changes approved amid active shareholder engagement.AKZA
AGM 202529 Nov 2025 - $17B all-stock merger targets $600M synergies, global scale, and industry-leading margins.AKZA
M&A Announcement18 Nov 2025 - Margins improved despite flat sales and currency headwinds, with major India divestment pending.AKZA
Q2 20254 Nov 2025 - Q3 margin rose to 15.1%, free cash flow improved, and India divestment is on track.AKZA
Q3 202522 Oct 2025